Georgia Healthcare Group PLC Annual Report 2018 Financial Statements Consolidated Statement of Changes In Equity For the year ended 31 December (thousands of Georgian Lari) Attributable to the shareholders of the Company Non- Additional Retained controlling Notes Share capitalTreasury share paid-in capitalOther reserves earnings Total interest Total equity 31 December 2016 4,784 (134) (200) 4,822 476,616 485,888 56,144 542,032 Effect from early adoption of IFRS 15 − − − − (1,049) (1,049) − (1,049) 1 January 2017 4,784 (134) (200) 4,822 475,567 484,839 56,144 540,983 Profit for the year – – – – 29,110 29,110 16,830 45,940 Other comprehensive loss – – – (4,460) – (4,460) (406) (4,866) Total comprehensive income – – – (4,460) 29,110 24,650 16,424 41,074 Non-controlling interests arising from business combinations – – – – (485) (485) 24,818 24,333 Acquisition of additional interest in existing subsidiaries 25 – – – (27,228) – (27,228) (34,798) (62,026) Purchase of treasury shares 25 – (3) (1,950) – – (1,953) – (1,953) Investment by non-controlling interest shareholder – – – – – – 2,128 2,128 Share-based compensation 31 – 3 3,858 – – 3,861 – 3,861 31 December 2017 4,784 (134) 1,708 (26,866) 504,192 483,684 64,716 548,400 Attributable to the shareholders of the Company Non- Additional Retained controlling Notes Share capitalTreasury share paid-in capitalOther reserves earnings Total interest Total equity 31 December 2017 4,784 (134) 1,708 (26,866) 504,192 483,684 64,716 548,400 Effect from adoption of IFRS 9 3 − − − − (6,535) (6,535) (492) (7,027) 1 January 2018 4,784 (134) 1,708 (26,866) 497,657 477,149 64,224 541,373 Profit for the year – – – – 34,434 34,43 4 18,805 53,239 Total comprehensive income – – – 34,434 34,434 18,805 53,239 Non-controlling interests arising from business combinations 5 – – – – – – 516 516 Acquisition of additional interest in existing subsidiaries 25 – – – (6,469) – (6,469) (3,789) (10,258) Purchase of treasury shares 25 – – (3,055) – – (3,055) – (3,055) Dividends declared to non-controlling interests by subsidiary – – – – – – (10,791) (10,791) Dilution of non-controlling interest – – – – – – (2,128) (2,128) Share-based compensation 38 – – 6,135 – – 6,135 – 6,135 31 December 2018 4,784 (134) 4,788 (33,335) 532,091 508,194 66,837 575,031 The accompanying notes on pages 128 to 175 form an integral part of these consolidated Financial Statements. 126